Alerts will be sent to your verified email
Verify Email
NORRIS
|
Norris Medicines
|
Venmax Drugs&Pharma
|
Link Pharma Chem
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
47.03 % | -44.32 % | 1.59 % |
|
5yr Avg Net Profit Margin
|
-30.66 % | -30.94 % | -0.06 % |
|
Price to Book
|
0.0 | 3.65 | 1.18 |
|
P/E
|
0.0 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
97.28 Days | 0.0 | 82.44 Days |
|
5yr Average Interest Coverage Ratio
|
-1.37 | -318.36 | 2.35 |
|
5yr Avg ROCE
|
-19.87 % | -45.33 % | 5.35 % |
|
5yr Avg Operating Profit Margin
|
-6.94 % | -50.41 % | 3.76 % |
|
5 yr average Debt to Equity
|
-3.0 | -0.64 | 0.49 |
|
5yr CAGR Net Profit
|
-15.97 % | n/a | n/a |
|
5yr Average Return on Assets
|
-18.92 % | 187.49 % | 0.6 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
34.0 % | 23.13 % | 51.49 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.04 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Norris Medicines
|
Venmax Drugs&Pharma
|
Link Pharma Chem
|
|---|